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Original Article 
Clinical and course indicators of bipolar disorder type I with and without  
opioid dependence 
 
Amir Shabani*a, Atefeh Ghanbari Jolfaeib, Hajar Ahmadi Vazmalaeib,  
Azizeh Afkham Ebrahimic, Morteza Naserbakhta 
 
Abstract 
BACKGROUND: The existing evidence about the clinical situations of the bipolar patients with opioid dependence is 
scarce. The present study was carried out to compare the clinical features and course of the bipolar disorder type I re-
garding the two subgroups of opioid dependent and non-dependent. 
METHODS: There were 178 adult patients with bipolar disorder type I consecutively referred to the Iran Hospital of Psy-
chiatry, Tehran, Iran, from January 2008 to January 2009 who enrolled in the study. The Persian Structured Clinical 
Interview for DSM-IV axis I disorders (SCID-I), HDRS-17, and Y-MRS were administered for all patients. Other clini-
cal information was gathered through the face-to-face interviews with the probands and the hospital records. The T test, 
Chi square test and logistic regression were used to analyze the data. 
RESULTS: The mean age of probands were 33.6 ± 11.1 years old and they were mostly male. Among the evaluated indi-
ces, the factors gender, anxiety disorders comorbidity, non-adherence, and positive family history were different sig-
nificantly and independently from the other studied factors between opioid dependent and non-dependent bipolar pa-
tients. 
CONCLUSIONS: Despite some differences, the opioid dependent and non-dependent bipolar patients did not have any 
significant difference regarding most of the examined clinical and course indices. 
KEYWORDS: Bipolar Disorder, Substance Dependence, Substance Abuse, Opioid, Outcome. 
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he substance abuse prevalence among 
patients with bipolar disorder (BD) has 
been between 17 and 65 percent.1 Based 
on the several studies the alcohol and cannabis 
have been estimated to be the most common 
abused substances by the BD patients.2 The 
cocaine and then opioids have stood on the 
next ranks.3 Nevertheless, a multi-center study 
in Iran showed that the opioid use disorder 
(OUD) is the most prevalent type of the sub-
stance use disorders (SUDs) in the clinical psy-
chiatric patients referred to the psychiatric 
hospitals.4 
 According to the various studies, the SUD 
comorbidity in patients with BD is in associa-
tion with particular features; e.g. earlier onset 
of BD, higher frequency of rapid cycling, and 
dysphoric and mixed states, higher rate of psy-
chiatric hospitalization, slower improvement 
of manic episode,5 more suicidal attempts,5-7 
higher rate of personality disorders comorbid-
ity and increased level of social dysfunction-
ing,8 more possibility of chronicity, disability, 
and mortality, more number of clinical symp-
toms and relapse, delayed remission, reduced 
time of relapsing,9 poorer therapeutic out-
T 
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come,5,10 lack of response to lithium,5 lower 
level of quality of life,11 and higher frequency 
of substance dependence than substance 
abuse.12 Nevertheless, the current knowledge 
is predominantly based on assessing the pa-
tients abusing alcohol or a mixed sample of 
individuals abusing various drugs, so that the 
patients with the use disorder of each certain 
substance remain to be settled. The signifi-
cance of this issue is particularly drawn from 
this finding that some clinical indices are re-
lated to the type of abused substance in pa-
tients with the comorbidity of BD and SUD. 
For example, Dalton et el 13 showed that the 
substance use disorder, but not the alcohol use 
disorder (AUD), was associated with the at-
tempted suicide rate in patients with BD. On 
the other hand, the mood stabilizing effects of 
the opioid drugs have been received attention 
specifically.2 Considering the mentioned issues 
and also this point that the opioids use preva-
lence in the Iranian in general 14 and clinical 4 
populations have been higher in comparison 
with the western ones, the present study was 
carried out to compare the clinical features and 
course of the bipolar disorder type I regarding 
the two subgroups of opioid dependent and 
non-dependent. 
Methods 
Participants 
A total of 178 inpatients with bipolar disorder 
type I consecutively referred to the Iran Hospi-
tal of Psychiatry, Tehran, Iran, from January 
2008 to January 2009 were enrolled in the 
study. 
 The patients who aged 18-65, were diag-
nosed as BD type I at least since two years ago, 
gave informed written consent, were able to 
take part in the interview, and had no mental 
retardation and history of substance abuse 
(with the exception of opioids, nicotine and 
caffeine) entered the study. Finally samples 
were consisted of 89 patients with and the 
same number without opioid dependence. Ac-
tually, the recruitment of the patients contin-
ued until the number of each subgroup par-
ticipants reached the number 89. 
 The project was approved by the Research 
Committee of the Department of Psychiatry, 
Iran University of Medical Sciences and Health 
Services. 
 
Procedure 
The Persian Structured Clinical Interview for 
DSM-IV axis I disorders (SCID-I),15 HDRS-17,16 
and Y-MRS 17,18 were administered for all pa-
tients. The SCID-I is a diagnostic tool which 
can be administered by a clinician. Its Persian 
version has had acceptable reliability, validity 
and feasibility on a large sample of Iranian pa-
tients.15 The HDRS-17 16 and Y-MRS 17,18 are the 
common and useful instruments to measure 
the severity of the mood symptoms. Also, 
demographic features, hospitalization rate, 
number of the months with non-compliance in 
the last year, age at the first major mood epi-
sode and at the first hospitalization, and family 
history (first-degree) for the major psychiatric 
disorders including psychotic, mood, anxiety 
and substance use disorders were identified. 
 Two trained last-year residents of psychia-
try (from Iran University of Medical Sciences 
and Health Services) did the face-to-face inter-
views with the probands. The patients were 
interviewed at the last days being in the hospi-
tal. The hospital records were another resource 
of the gathered information. 
 
Statistical Analysis 
The data was analyzed by the Software Pack-
age for Social Sciences (SPSS, version 14). Also 
the T test, Chi square test, and logistic regres-
sion were used to analyze the findings. 
Results 
The mean age of probands were 33.6 ± 11.1 
years old and they were mostly male (77.5%). 
The demographic features of the opioid de-
pendent and non-dependent patients with BD 
are seen in table 1. According to this table, 
gender ratio, and marital and occupational 
status were significantly different between the 
two groups. 
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Table 1. Demographic features of the participants with bipolar I disorder (n = 178).  
Data are mean ± SD or n (%) 
Variable Opium dependent (n = 89) 
Non opium dependent 
(n = 89) P value 
Male  79 (88.7) 59 (66.3) 0.01 
Marital status  
Never married 
Married  
Divorced 
 
32 (36.0) 
42 (47.2) 
15 (16.9) 
 
49 (55.1) 
31 (34.8) 
9 (10.1) 
0.02 
Age (years)  33.4 ± 10.8 34.4 ± 11.2 NS* 
Education  
Under diploma 
Diploma  
College 
 
63 (72.4) 
20 (23.0) 
4 (4.6) 
 
53 (59.6) 
26 (29.2) 
10 (11.2) 
NS 
Occupation  ** 
Unemployed 
Employed 
Housewife 
 
59 (66.3) 
24 (27.0) 
6 (6.7) 
 
49 (55.1) 
14 (15.7) 
26 (29.2) 
0.001 
* Non-significant;    ** There was missing information about two cases. 
 
 The clinical features of the opioid depend-
ent and non-dependent patients with bipolar 
disorder type I are presented in table 2. Among 
these features, three items including anxiety 
disorders comorbidity, non-adherence to 
pharmacotherapy, and positive family history 
of major psychiatric disorders were signifi-
cantly different between two mentioned 
groups (p < 0.001). 
 The variables which were different signifi-
cantly between the opioid dependent and non-
dependent groups were analyzed using the 
logistic regression analysis (Table 3). As seen
 
Table 2. Clinical features of the opioid dependent and non-dependent patients with bipolar I  
disorder (n = 178). Data are mean ± SD or n (%) 
Variable 
Opioid  
dependent 
(n = 89) 
Non opioid 
dependent 
(n = 89) 
P value 
Anxiety disorders comorbidity  65 (73.0)  35 (39.3) 0.001 
Current mood episode  
Manic 
Major depressive 
Mixed 
 
56 (62.9) 
15 (16.9) 
18 (20.2) 
 
64 (71.9) 
15 (16.9) 
10 (11.2) 
 
NS* 
Type of index episode  
Manic 
Major depressive 
Mixed 
49 (55.1) 
30 (33.7) 
10 (11.2) 
65 (73.0) 
19 (21.3) 
5 (5.6) 
NS 
Age at the first hospitalization (years)  24.8 ± 7.1 26.3 ± 8.9 NS 
Age at the first major mood episode (years)  23.7 ± 6.5 24.7 ±8.7 NS 
Number of hospitalizations  4.1 (2.8) 3.5 (2.4) NS 
No pharmacotherapy in one year 
(months)  7.8 ± 4.7 5.4 ± 4.3 0.001 
HDRS-17 (mean) 7.3 (7.0) 5.7 (4.8) NS 
Y-MRS (mean ) 29.6 (12.8) 30 (12.9) NS 
Positive family history **  41 (46.1) 57 (64.8) 0.001 
* Non-significant; ** There was missing information about one case. 
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Table 3. The associations of different variables with the opioid dependence in patients with bipo-
lar I disorder through a logistic regression analysis 
Variable β SE Wald df P EXP B 
95.0% C.I. for EXP(B) 
    Lower           Upper 
Gender 2.626 0.706 13.840 1 0.000 13.821 3.465 55.137 
Marital status 0.220 0.293 0.565 1 0.452 0.802 452 1.425 
Occupation status 0.424 0.356 1.415 1 0.234 1.528 760 3.073 
Anxiety disorders 
comorbidity 
1.561 0.379 16.948 1 0.000 4.762 2.265 10.011 
Non-adherence 0.091 0.043 4.452 1 0.035 1.095 1.006 1.192 
Positive family 
history 
0.799 0.368 4.706 1 0.030 2.224 1.080 4.579 
 
in this table, each of the factors gender, anxiety 
disorders comorbidity, non-adherence, and 
positive family history is different significantly 
and independently from the other studied fac-
tors between opioid dependent and non-
dependent bipolar patients. Therefore, other 
demographic factors which were different be-
tween the two groups based on the simple 
tests (marital and occupational status), did not 
have any significant difference after logistic 
regression. 
Discussion 
This study demonstrated no significant differ-
ence between dependent and non-dependent 
bipolar type I patients considering most of the 
assessed clinical variables; i.e. type of the index 
mood episode, type of the current mood epi-
sode, age at the first major mood episode and 
the first hospitalization, number of hospitaliza-
tions, and severity of the current mood symp-
toms. Given that there is a little information 
about the clinical situation and course of the 
comorbidity of opioid dependence and BD, 
comparison of the present findings with the 
data of the studies on the BD patients with 
SUD indicates an inconsistency. Based on the 
previous studies, BD in the patients with SUD 
has common features such as starting at the 
lower age, higher severity of clinical symp-
toms, increased recurrence, slower and poorer 
response to treatment, more impairment in 
functioning, and lower level of quality of life. 
For example, Himmelhoch et al 19 and Keller et 
al 20 showed that these patients experienced 
more severe manifestations of BD like rapid 
cycling, dysphoric mania and mixed state. 
Also, in patients with co-occurrence of BD and 
AUD, AUD was associated with psychosis 
within first mood episode which pointed out 
the high level of severity of the indexed epi-
sode.21 More severity of BD among patients 
with SUD could be observed reviewing the 
studies which have demonstrated more distur-
bances in social functioning,8,21 increased dis-
ability and mortality,7 and more episodic re-
currence 22,23 in these patients. Moreover, qual-
ity of life–the index has received much atten-
tion in recent years–has been measured in the 
individuals with BD and its decreased level 
has been reported.11 Another important factor 
with the demonstrated relationship with 
higher severity and poorer outcome of mood 
disorder 24-27 is "age at onset". The low age at 
onset of BD in patients with SUD has been re-
ported repeatedly 5,9 that could be a more em-
phasis on the fact that the severity of BD asso-
ciated with SUD is more than of BD without 
any SUDs. Finally, decreased response of pa-
tients with this dual diagnosis to pharmaco-
therapy for BD indicates the poorer prognosis 
of this comorbidity. 
 Therefore, given that in the present study 
there were not significant differences between 
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the two groups of probands with and without 
OUD for most of the evaluated factors, the 
most important finding of this study might be 
the existing of a probable difference between 
the effect of OUD comorbidity and of sub-
stance use disorders in general on the clinical 
situation and course of bipolar disorder. In 
other word, a specific effect from opioid abuse 
was seen that could have some implications 
and propose some hypotheses. 
 Nevertheless, this study showed a few sig-
nificant differences between the dependent 
and non-dependent BD patients: gender, posi-
tive family history for psychiatric disorders, 
anxiety disorders comorbidity and non-
adherence. The difference in gender ratio 4,14 
was according to the previous evidence highly 
predictable, but about the difference in the rate 
of positive family history, the findings in the 
literature are conflicting 21,28 and difficult to 
reconcile. 
 The anxiety disorders are common not only 
in the patients with BD 29,30 but also in the SUD 
cases.31,32 A study by Kolodziej et al proposed 
an increase in substance use disorders (espe-
cially cocaine and amphetamine) frequency 
among patients with the comorbidity of BD 
and posttraumatic stress disorder (but not 
other anxiety disorders).33 The present study in 
line with the previous ones indicates that the 
rate of anxiety disorders co-occurrence in bipo-
lar patients with SUD is high. Another finding 
is that the mentioned increment is independent 
from other contributing evaluated factors and 
consequently is valid. Hence, to manage the 
patients with BD and concurrent opioid de-
pendence, the clinicians should probe for any 
anxiety symptoms and disorders and treat 
them. Also, regarding the high frequency of 
co-occurrence of BD, SUD and anxiety disor-
ders, it is suggested that the clinical features, 
course and treatment of this triad be studied. 
 The two groups of individuals with and 
without OUD were different in terms of phar-
macotherapy compliance that is consistent 
with the literature.10,34,35 To explain why the 
mood stabilizing treatment adherence is de-
creased in bipolar patients with SUD, some 
hypotheses are proposed which need to be 
tested; e.g. the substances are able to subside 
the mood symptoms 36; the substances would 
be able to change patients' insight to the men-
tal disorder; the cultural beliefs might change 
the patients' attitude toward pharmacotherapy; 
substance-drug interactions may lead to some 
adverse events resulting in poor compliance; 
and the specific effects of BD-SUD comorbidity 
might be a key for reaching the proper answer. 
Based on the authors' experience in the Iranian 
culture, some patients believe in the therapeu-
tic effects of opium. They imagine that they 
should use either one for going on the therapy: 
opium or prescribed drug! So, they may state 
that they have stopped the medication because 
of starting opium use! 
Conclusions 
To sum up, despite the difference in anxiety 
disorders comorbidity and non-adherence rate 
between the opioid dependent and non-
dependent bipolar patients, the two groups did 
not have any significant difference for most of 
the examined clinical and course indices. 
Hence, some hypotheses are presented about 
the relationships between opioid use and bipo-
lar disorder which each one needs to be inves-
tigated through future studies. However, the 
present findings should be settled considering 
the methodological limitations. Given non-
random sampling, the sample was not inevita-
bly representative. Furthermore, the substance 
that the patients were dependent on was sim-
ply from opioid group and not alcohol nor 
other substances concurrently. Thus it should 
be considered that the findings are just related 
to opioid drugs. These data were obtained 
through a cross-sectional and retrospective as-
sessment and a few of them were not gathered 
based on a standardized instrument. Also, hav-
ing an anamnestic approach to getting some 
historical data could be another limitation. Re-
garding some other important clinical features 
like quality of life, and doing prospective and 
longitudinal studies, therapeutic interventions, 
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and biological investigations, like genetic and 
basic science studies will prepare more evi-
dence on the matter of similarities and dissimi-
larities of these two groups of patients with 
bipolar disorder. 
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